Percutaneous coronary intervention in acute myocardial infarction with cardiogenic shock: immediate and late outcomes

S Srimahachota1, S Boonyaratavej, W Udayachalerm

  • 1Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Insights

Percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) with cardiogenic shock may lower mortality. Early revascularization via PCI offers better outcomes for these high-risk patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Critical Care Medicine

Background:

  • Acute myocardial infarction (AMI) complicated by cardiogenic shock has a high mortality rate.
  • Early revascularization strategies are associated with improved outcomes compared to conservative management.

Purpose of the Study:

  • To evaluate the short- and long-term results of percutaneous coronary intervention (PCI) in patients experiencing cardiogenic shock secondary to AMI.
  • To assess the efficacy and safety of early revascularization in this high-risk patient population.

Main Methods:

  • Retrospective analysis of patients undergoing PCI from 1993 to 1999.
  • Data collected from a PCI registry and patient medical records, including follow-up information.
  • Identification of 17 patients with cardiogenic shock among 1211 PCI procedures.

Main Results:

  • The study included 17 patients (9 male, 8 female) with cardiogenic shock, mean age 59 years.
  • Eleven patients underwent primary PCI; 13 required intra-aortic balloon pump support.
  • In-hospital mortality was 29.4% (5 patients), with 3 deaths on day one due to pump failure. Long-term follow-up showed one late death due to in-stent restenosis.

Conclusions:

  • Despite high mortality associated with AMI and cardiogenic shock, early revascularization with PCI appears to reduce mortality compared to historical data.
  • PCI should be considered as a treatment option for selected AMI patients presenting with cardiogenic shock.
  • The findings suggest that timely intervention with PCI can improve outcomes in this critical subgroup of AMI patients.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...